JP2014504646A5 - - Google Patents

Download PDF

Info

Publication number
JP2014504646A5
JP2014504646A5 JP2013552637A JP2013552637A JP2014504646A5 JP 2014504646 A5 JP2014504646 A5 JP 2014504646A5 JP 2013552637 A JP2013552637 A JP 2013552637A JP 2013552637 A JP2013552637 A JP 2013552637A JP 2014504646 A5 JP2014504646 A5 JP 2014504646A5
Authority
JP
Japan
Prior art keywords
alkyl
isopropoxy
chloro
medicament
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013552637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014504646A (ja
JP5837095B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/023669 external-priority patent/WO2012106540A1/en
Publication of JP2014504646A publication Critical patent/JP2014504646A/ja
Publication of JP2014504646A5 publication Critical patent/JP2014504646A5/ja
Application granted granted Critical
Publication of JP5837095B2 publication Critical patent/JP5837095B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013552637A 2011-02-02 2012-02-02 Alk阻害剤の使用方法 Active JP5837095B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438878P 2011-02-02 2011-02-02
US61/438,878 2011-02-02
PCT/US2012/023669 WO2012106540A1 (en) 2011-02-02 2012-02-02 Methods of using alk inhibitors

Publications (3)

Publication Number Publication Date
JP2014504646A JP2014504646A (ja) 2014-02-24
JP2014504646A5 true JP2014504646A5 (cg-RX-API-DMAC7.html) 2014-07-24
JP5837095B2 JP5837095B2 (ja) 2015-12-24

Family

ID=45582065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013552637A Active JP5837095B2 (ja) 2011-02-02 2012-02-02 Alk阻害剤の使用方法

Country Status (22)

Country Link
US (1) US8703787B2 (cg-RX-API-DMAC7.html)
EP (1) EP2670401B1 (cg-RX-API-DMAC7.html)
JP (1) JP5837095B2 (cg-RX-API-DMAC7.html)
KR (1) KR101521861B1 (cg-RX-API-DMAC7.html)
CN (1) CN103458881B (cg-RX-API-DMAC7.html)
AU (1) AU2012212142B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013019643B1 (cg-RX-API-DMAC7.html)
CA (1) CA2824092C (cg-RX-API-DMAC7.html)
CY (1) CY1116662T1 (cg-RX-API-DMAC7.html)
DK (1) DK2670401T3 (cg-RX-API-DMAC7.html)
EA (1) EA023404B1 (cg-RX-API-DMAC7.html)
ES (1) ES2543567T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20150946T1 (cg-RX-API-DMAC7.html)
HU (1) HUE025395T2 (cg-RX-API-DMAC7.html)
ME (1) ME02200B (cg-RX-API-DMAC7.html)
MX (1) MX2013008791A (cg-RX-API-DMAC7.html)
PL (1) PL2670401T3 (cg-RX-API-DMAC7.html)
PT (1) PT2670401E (cg-RX-API-DMAC7.html)
RS (1) RS54189B1 (cg-RX-API-DMAC7.html)
SI (1) SI2670401T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201500300B (cg-RX-API-DMAC7.html)
WO (1) WO2012106540A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104854101B (zh) 2012-11-06 2018-05-01 上海复尚慧创医药研究有限公司 Alk激酶抑制剂
RU2015121424A (ru) * 2012-11-07 2016-12-27 Новартис Аг Комбинированная терапия
CN104109149B (zh) 2013-04-22 2018-09-28 苏州泽璟生物制药有限公司 氘代的二氨基嘧啶化合物以及包含该化合物的药物组合物
ITMI20131124A1 (it) 2013-07-04 2015-01-05 Univ Milano Bicocca 2-acilamminotiazoli per il trattamento del cancro
WO2015003658A1 (en) * 2013-07-11 2015-01-15 Betta Pharmaceuticals Co., Ltd Protein tyrosine kinase modulators and methods of use
JP6479812B2 (ja) * 2013-08-28 2019-03-06 ノバルティス アーゲー 細胞増殖性疾患を治療するためのalk阻害剤とcdk阻害剤との組合せ
CN104672214B (zh) * 2013-12-03 2019-04-12 上海翰森生物医药科技有限公司 具有alk抑制活性的化合物及其制备与用途
KR20160100975A (ko) * 2013-12-23 2016-08-24 노파르티스 아게 제약 조합물
CN104876914B (zh) * 2014-02-28 2017-04-19 山东轩竹医药科技有限公司 嘧啶衍生物类间变性淋巴瘤激酶抑制剂
KR101656382B1 (ko) * 2014-02-28 2016-09-09 한국화학연구원 피리미딘-2,4-디아민 유도체 및 이를 유효성분으로 함유하는 항암용 약학적 조성물
EP3159338A4 (en) * 2014-06-17 2018-01-24 Korea Research Institute of Chemical Technology Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient
CN105524045B (zh) * 2014-10-22 2020-04-10 山东轩竹医药科技有限公司 四环类间变性淋巴瘤激酶抑制剂
CN106146525B (zh) * 2015-04-10 2018-11-02 山东轩竹医药科技有限公司 三并环类间变性淋巴瘤激酶抑制剂
EP3287463A4 (en) 2015-04-24 2018-07-11 Guangzhou Maxinovel Pharmaceuticals Co., Ltd. Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
CN106699743B (zh) 2015-11-05 2020-06-12 湖北生物医药产业技术研究院有限公司 嘧啶类衍生物及其用途
CN106220608B (zh) * 2016-07-25 2018-11-27 安润医药科技(苏州)有限公司 二苯氨基嘧啶及三嗪化合物、其药用组合物及用途
CN107698603B (zh) * 2016-08-09 2022-04-08 南京红云生物科技有限公司 噻吩并嘧啶类化合物、其制备方法、药用组合物及其应用
WO2018044767A2 (en) * 2016-08-29 2018-03-08 The Regents Of The University Of Michigan Aminopyrimidines as alk inhibitors
CN111484484B (zh) * 2020-04-13 2021-11-23 沈阳药科大学 含芳杂环的2,4-二芳氨基嘧啶衍生物及其制备与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
SI2287156T1 (sl) * 2003-08-15 2013-09-30 Novartis Ag 2,4-di(fenilamino)-pirimidini, uporabni pri zdravljenju neoplastičnih bolezni, vnetnih motenj in motenj imunskega sistema
GB0419161D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
WO2008007368A2 (en) 2006-07-10 2008-01-17 Rf Dynamics Ltd. Food preparation
CA2598893C (en) * 2006-10-11 2012-04-10 Astellas Pharma Inc. Eml4-alk fusion gene
EP2311807B1 (en) * 2006-12-08 2015-11-11 Novartis AG Compounds and composition as protein kinase inhibitors
WO2008073687A2 (en) 2006-12-08 2008-06-19 Irm Llc Compounds and compositions as protein kinase inhibitors
KR101238585B1 (ko) * 2008-04-07 2013-02-28 노파르티스 아게 단백질 키나제 억제제로서의 화합물 및 조성물

Similar Documents

Publication Publication Date Title
JP2014504646A5 (cg-RX-API-DMAC7.html)
JP2013537203A5 (cg-RX-API-DMAC7.html)
JP2017504611A5 (cg-RX-API-DMAC7.html)
JP2015512931A5 (cg-RX-API-DMAC7.html)
JP2017538773A5 (cg-RX-API-DMAC7.html)
JP2017526711A5 (cg-RX-API-DMAC7.html)
HRP20150946T1 (hr) Postupci uporabe alk-inhibitora
JP2011519854A5 (cg-RX-API-DMAC7.html)
JP2017502940A5 (cg-RX-API-DMAC7.html)
JP2015508103A5 (cg-RX-API-DMAC7.html)
JP2016540742A5 (cg-RX-API-DMAC7.html)
JP2013544860A5 (cg-RX-API-DMAC7.html)
JP2012097115A5 (cg-RX-API-DMAC7.html)
JP2015518894A5 (cg-RX-API-DMAC7.html)
JP2015505296A5 (cg-RX-API-DMAC7.html)
JP2013505969A5 (cg-RX-API-DMAC7.html)
JP2016503799A5 (cg-RX-API-DMAC7.html)
JP2013533879A5 (cg-RX-API-DMAC7.html)
JP2011527666A5 (cg-RX-API-DMAC7.html)
JP2012510502A5 (cg-RX-API-DMAC7.html)
JP2012507535A5 (cg-RX-API-DMAC7.html)
JP2018530582A5 (cg-RX-API-DMAC7.html)
JP2014526533A5 (cg-RX-API-DMAC7.html)
JP2013506674A5 (cg-RX-API-DMAC7.html)
JP2013502441A5 (cg-RX-API-DMAC7.html)